Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Interventional × elacestrant × Clear all

Phase

Status

Recruiting 10 Completed 4 Not yet recruiting 3 Active not recruiting 3 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Cyclophosphamide 336 Carboplatin 285 pembrolizumab 267 Gemcitabine 267 Cisplatin 260 Radiotherapy 248 Paclitaxel 248 Docetaxel 244 Bevacizumab 207 Rituximab 199 Capecitabine 185 Nivolumab 177 Dexamethasone 169 Fluorouracil 167 fludarabine 154 Oxaliplatin 148 Doxorubicin 133 Irinotecan 125 Leucovorin 124 Etoposide 123 Pemetrexed 122 Cytarabine 121 Bortezomib 107 fludarabine phosphate 106 Filgrastim 102 Cetuximab 102 Lenalidomide 101 Erlotinib Hydrochloride 98 Temozolomide 91 Trastuzumab 90

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05618613 2025-05-09

ELONA

Context Therapeutics Inc.

Phase 1/2 Terminated

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡